Podcasts From The Cochrane Library

Do biosimilar monoclonal antibodies perform as well as the original medicine for cancer treatment?

Informações:

Sinopsis

Alongside Cochrane Reviews of the effects of original drugs for the treatment of some diseases, reviews are starting to appear of the effects of biosimilars for these drugs. In this podcast, Roses Parker, Cochrane’s Commissioning Editor tells us about the evidence in one of these reviews, published in November 2024, which considers biosimilar monoclonal antibodies for the treatment of patients with cancer.